Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Drug Pricing

May 02, 2018 | Daily News

The Pharmaceutical Research and Manufacturers of America and the Biotechnology Innovation Organization are attempting to use the generic lobby’s recent legal victory against Maryland's price-gouging law to boost their efforts to block a drug-pricing law in Nevada. PhRMA is taking a similar tact in California.

May 01, 2018 | Daily News

CMS Administrator Seema Verma said Tuesday (May 1) that agency staff are working through legal issues in an effort to let states use restricted Medicaid formularies that would give them more leverage in price negotiations with brand drug makers.

May 01, 2018 | Daily News

CMS Administrator Seema Verma said Tuesday (May 1) that agency staff are working through legal issues in an effort to let states use restricted Medicaid formularies that would give them more leverage in price negotiations with brand drug makers.

May 01, 2018 | Daily News

The Health Resources and Services Administration withdrew Monday (April 30) a proposed rule to modify an Obama-era regulation on 340B ceiling prices and penalties, according to the White House Office of Management and Budget, which had been reviewing the proposed rule since October.

April 27, 2018 | Daily News

The Federal Trade Commission, for the first time in its history, will install five new commissioners at once, and there is debate as to how this leadership shake-up will affect the commission’s health care priorities.

April 27, 2018 | Daily News

The Congressional Black Caucus is throwing its support behind 340B hospitals and health clinics, coming as Rep. Doris Matsui (D-HI) also seeks to boost the hospitals by drafting a bill that requires audit parity between 340B hospitals and drug makers.

April 26, 2018 | Daily News

Knowledge Ecology International is suing the National Institutes of Health over the agency’s plan to issue Kite Pharma an exclusive license to a government-developed CAR-T cancer therapy.

April 24, 2018 | Daily News

Rep. Buddy Carter (R-GA) introduced a bill Tuesday (April 24) that would make 340B hospitals report on how many low-income patients are cared for as inpatients and outpatients -- including patients at off-campus pediatric sites.

April 24, 2018 | Daily News

The U.S. Supreme Court ruled 7-2 Tuesday (April 24) that the Patent and Trademark Office's inter partes review process does not violate the constitution even though it doesn’t provide the same guardrails as federal courts, marking a major win for generic drug makers and a loss for brand manufacturers.

April 24, 2018 | Daily News

The U.S Supreme Court decided 5-4 Tuesday (April 24) that the Patent Trial and Appeal Board may not choose to decide the validity of a subset of patents challenged in an inter partes review, and instead must make a determination as to all of the patents challenged.

April 20, 2018 | Daily News

Rheumatologists are developing an alternative pay model to cut rebate-driven pharmacy benefit managers out of the drug channel.

April 19, 2018 | Daily News

FDA Commissioner Scott Gottlieb provided the first indications Thursday (April 19) as to what policies are likely to be included in his upcoming plan to boost biosimilar development, namely lowering the bar for demonstrating interchangeability and making it easier for biosimilars to extrapolate across indications -- moves that track with a White House drug pricing report put out earlier this year.

April 19, 2018 | Daily News

Those wondering what is in President Donald Trump’s plan to lower drug costs shouldn’t bother asking Congress because lawmakers, including GOP leaders, don’t know, several sources have heard from congressional staff, and an adviser to HHS Secretary Alex Azar declined to describe even the regulatory procedure that HHS will use to execute the plan.

April 19, 2018 | Daily News

The newly appointed top HHS official on opioid policy faced tough questions Thursday (April 19) from Democrats on the Senate Finance Committee about whether he would take aggressive action against opioid manufacturers and distributors, and the committee’s ranking Democrat, Sen. Ron Wyden (OR), said the committee should summon the executives of those companies to testify about their role in the opioid crisis.

April 18, 2018 | Daily News

The White House Office of Management and Budget is reviewing a notice expected to be part of the president’s April 26 announcement of a plan to lower drug costs, and lobbyists are taking the review as a sign the plan will ask for feedback on either Medicare Part D rebates or Part B policies.

April 18, 2018 | Daily News

Brand drug maker representatives met with CMS and White House budget officials to push for higher Medicare hospital inpatient reimbursement through changes to the MS-DRG system and the New Technology Add-on Payments, about which industry has raised concerns for years.

April 18, 2018 | Daily News

Patient advocacy groups weighed in on ways to make drugs and the health care system as a whole more affordable at a Tuesday (April 17) meeting with HHS Deputy Secretary Eric Hargan. The meeting took place a week before President Donald Trump is slated to unveil his plan to reduce prescription drug prices.

April 17, 2018 | Daily News

The ongoing battle between the insurance industry and a charity that supports end-stage renal disease patients by covering their commercial insurance payments heated up Tuesday (April 17) with both parties seeking immediate action by HHS Secretary Alex Azar.

April 16, 2018 | Daily News

President Trump is tentatively scheduled to announce on April 26 his plan to curb the growth in drug prices, and that speech will coincide with a request for advice from the public and will include references to policies in Trump’s budget, Deputy White House Press Secretary Hogan Gidley said.

April 13, 2018 | Daily News

A federal appeals court handed the generic drug industry a major win Friday (April 13) by ruling against Maryland's first-in-the-nation generic drug price gouging law.

Pages